The Guardian
17 Oct 2026, 06:00 UTC · 4h ago
Palantir patient data tech rejected by many NHS trusts in England
Impact · against what's priced in
The rejection of Palantir's platform by 16 NHS trusts increases the probability that the UK government will trigger the break clause in its £330m contract. This undermines the assumed convergence of government revenue growth toward corporate rates by introducing a concrete risk of contract termination.
- PLTR−0.40
Challenges what's priced in
- The price assumes
Current government revenue growth of roughly 90% decelerating to match the blended corporate rate.
The market assumes government growth will simply slow down to corporate levels; however, the rejection of the platform by 16 trusts and the government's looming decision on a break clause suggest the risk is not just deceleration, but a total loss of a £330m revenue stream.
What PLTR's price assumes · Sep 10
Search tags
